Anti-Cytomegalovirus Activity of Atanyl Blue PRL, an Anthraquinone Derivative
Cytomegalovirus (CMV) is a significant cause of mortality and morbidity in immunocompromised patients and an important cause of birth defects if acquired in utero. The licensed CMV antivirals, ganciclovir, cidofovir and foscarnet, all target the viral DNA polymerase. For each drug prolonged use is a...
Main Author: | Alam, Zohaib |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2013
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/3166 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=4165&context=etd |
Similar Items
-
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
by: El Helou G, et al.
Published: (2019-06-01) -
Identification of UL69 Gene and Protein in Cytomegalovirus-Transformed Human Mammary Epithelial Cells
by: Sandy Haidar Ahmad, et al.
Published: (2021-04-01) -
Genotipagem do citomegalovírus humano para pesquisa de resistência primária aos antivirais em transplantados renais
by: Carraro Emerson, et al.
Published: (2004-01-01) -
Human Cytomegalovirus Interleukin 10 Homologs: Facing the Immune System
by: Emma Poole, et al.
Published: (2020-06-01) -
The Role of pUL138 In HCMV Persistence
by: Petrucelli, Alexius
Published: (2011)